Robert Zerbe

Robert Zerbe

Net worth: 1 M $ as of 2026-05-30

75 year
Health Technology
Miscellaneous
Consumer Services

Profile

Dr. Robert L.
Zerbe
, MD, is an Independent Director at Cirius Therapeutics, Inc. and a Chairman at Vericel Corp.
He is on the Board of Directors at Cirius Therapeutics, Inc. and Indiana University Foundation, Inc. Dr. Zerbe was previously employed as an Independent Director by Optimer Pharmaceuticals LLC, a President, Chief Executive Officer & Director by QuatRx Pharmaceuticals Co., a SVP-Worldwide Clinical Research & Development by Parke-Davis &Co. (United States), a Senior VP-Global Research & Development by Pfizer Inc., a SVP-Worldwide, Clinical Research & Development by Warner-Lambert Co., a VP-Clinical Investigation & Regulatory Affairs by Eli Lilly & Co., a Managing Director by Lilly Research Center Ltd., and a President & Chief Executive Officer by Hormos Medical Oy.
He also served on the board at Metabolic Solutions Development Co. LLC, Anesiva, Inc., A.P.
Pharma, Inc., CymaBay Therapeutics, Inc., Edgemont Pharmaceuticals LLC and Maxim Pharmaceuticals, Inc. He received his doctorate degree from The Indiana University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-28 32,995 ( 0.06% ) 1 M $ 2026-05-30

Robert Zerbe active positions

CompaniesPositionStart
VERICEL CORPORATION Chairman 2012-10-04
Director/Board Member -
Director/Board Member 2016-04-30

Former positions of Robert Zerbe

CompaniesPositionEnd
Founder 2016-06-30
Director/Board Member 2013-10-23
HERON THERAPEUTICS, INC. Director/Board Member 2011-04-17
Director/Board Member 2008-12-14
Director/Board Member 2006-01-05
See the detail of Robert Zerbe's experience

Training of Robert Zerbe

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology